Can Xencor (XNCR) Climb 48% to Reach the Level Wall Street Analysts Expect?Zacks Investment Research • 10/27/21
4 Small Drug Stocks That Hold Promise Despite Industry ChallengesZacks Investment Research • 10/27/21
Wall Street Analysts See a 55% Upside in Xencor (XNCR): Can the Stock Really Move This High?Zacks Investment Research • 10/11/21
JNJ, Xencor Sign $1.3B Licensing Deal For B-Cell Malignancies-Targeted Bispecific AntibodyBenzinga • 10/04/21
Xencor Enters Global Collaboration and License Agreement With Janssen to Advance Plamotamab and XmAb CD28 Bispecific Antibody Combinations for the Treatment of Patients With B-Cell MalignanciesBusiness Wire • 10/04/21
Xencor to Present Data from the Phase 1 Study of Vudalimab (XmAb®717) and Four Research Programs at the SITC Annual MeetingBusiness Wire • 10/01/21
Xencor, Inc. (XNCR) CEO Bassil Dahiyat on Q2 2021 Results - Earnings Call TranscriptSeeking Alpha • 08/05/21
Xencor to Host Second Quarter 2021 Financial Results Webcast and Conference Call on August 4, 2021Business Wire • 07/28/21
Xencor (XNCR) May Report Negative Earnings: Know the Trend Ahead of Q2 ReleaseZacks Investment Research • 07/27/21
Down 10.9% in 4 Weeks, Here's Why Xencor (XNCR) Looks Ripe for a TurnaroundZacks Investment Research • 07/27/21
5 Mid-Cap Healthcare Stocks You'll Want on Your Radar for the 2nd Half of 2021The Motley Fool • 07/23/21
Xencor (XNCR) Loses 12.1% in 4 Weeks, Here's Why a Trend Reversal May be Around the CornerZacks Investment Research • 06/30/21
4 Small Drug Stocks Set to Escape the COVID-Led Industry WeaknessZacks Investment Research • 06/21/21
Sotrovimab (VIR-7831), an Investigational Antibody Utilizing Xencor's Xtend™ Technology, Receives U.S. FDA Emergency Use Authorization for the Treatment of COVID-19Business Wire • 05/26/21
Xencor and Bristol Myers Squibb Enter License Agreement for Use of Xtend™ XmAb® Technology in SARS-CoV-2 Neutralizing Monoclonal Antibody Combination for the Treatment of COVID-19Business Wire • 05/25/21
Xencor to Present at the 2021 RBC Capital Markets Global Healthcare Virtual ConferenceBusiness Wire • 05/12/21
Xencor, Inc. (XNCR) CEO Bassil Dahiyat on Q1 2021 Results - Earnings Call TranscriptSeeking Alpha • 05/08/21